Preview Mode Links will not work in preview mode

Oct 14, 2020

Featuring an interview with Dr John M Pagel about recently published and emerging research in the front-line treatment of chronic lymphocytic leukemia, including the following topics:

  • New treatment paradigms in chronic lymphocytic leukemia (CLL) — John M Pagel, MD, PhD (00:00)
  • Case: A man in his late 50s...


Oct 9, 2020

Featuring a discussion on recent advances in the treatment of Hodgkin lymphoma with Dr Craig Moskowitz, including the following topics:

  • Hodgkin lymphoma 2020: What are the important questions in up-front therapy? — Craig Moskowitz, MD (00:00)
  • Case: A woman in her early 20s with relapsed/refractory Stage IV classical...


Sep 30, 2020

Featuring an interview with Dr Jeffrey E Lancet about recent data with induction and maintenance therapy for acute myeloid leukemia, including the following topics:

  • Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia — Jeffrey E Lancet, MD (00:00)
  • Case: A man in his late 60s with secondary AML,...


Sep 25, 2020

Featuring an interview with Dr Srdan Verstovsek about recently published and emerging research in the management of myeloproliferative neoplasms, including the following topics:

  • Management of myeloproliferative neoplasms — Srdan Verstovsek, MD, PhD (00:00)
  • Case: A woman in her early 50s with myelofibrosis (MF) and...


Sep 24, 2020

Proceedings from a webinar on acute myeloid leukemia with Dr Eytan Stein covering the following topics:

  • Introduction (00:00)
  • Bcl-2 inhibition as a rational therapeutic strategy (1:02)
  • FLT3 Inhibitors in the Up-Front and Recurrent Settings (24:00)
  • IDH inhibitors in the Up-Front and Recurrent Settings (47:57)